Paula Green, SVP of Human Resources at Twist Bioscience Corp, filed a Form 4 on November 18, 2026, disclosing a mandatory tax-withholding sale of common stock and a new restricted stock unit award, both dated November 16, 2026.

Key Highlights

  • Tax-withholding sale: Green disposed of 4,281 shares of common stock at $103.688 per share on November 16, 2026, to cover tax obligations connected to the vesting of Performance Stock Units.
  • Mandatory, not discretionary: According to the filing, the sale was mandated by the issuer's equity incentive plan election and does "not represent discretionary trades by the Reporting Person."
  • New RSU award: Green received 6,372 restricted stock units at $0, with vesting at 1/16th of the total on each quarterly anniversary of November 16, 2026, over 48 months.
  • Post-transaction ownership: Following both transactions, Green directly beneficially owns 128,145 shares of common stock.
  • Exchange and issuer: Twist Bioscience Corp is listed as NASDAQ:TWST.

Green's PSU Tax Sale and New RSU Grant at Twist Bioscience

According to the Form 4 filed with the SEC on November 18, 2026, Paula Green, identified as SVP of Human Resources at Twist Bioscience Corp (NASDAQ:TWST), reported two transactions in the company's common stock, both occurring on November 16, 2026. The first was a disposition of 4,281 shares at a price of $103.688 per share. The filing states this sale represents shares required to be sold to cover tax withholding obligations arising from the vesting of Performance Stock Units, and that such sales are "mandated by the Issuer's election under its equity incentive plans." The filing explicitly notes the transaction does not reflect a discretionary trade by Green.

The second transaction was an acquisition of 6,372 shares in the form of a restricted stock unit award at a price of $0. Per the filing, the RSUs vest at a rate of 1/16th of the total on each quarterly anniversary of November 16, 2026, over a total vesting period of 48 months, subject to Green's continuous service through each vesting date. Both transactions are reported as direct ownership.

After accounting for both the disposal and the new RSU award, the filing states Green's total direct beneficial ownership of Twist Bioscience common stock stands at 128,145 shares. The Form 4 was signed by Kendra Fox as Attorney-in-Fact for Paula Green and dated November 18, 2026.

What Was Disclosed

Twist Bioscience SVP of Human Resources Paula Green filed a Form 4 reporting a mandated tax-withholding sale of 4,281 shares at $103.688 and a new 6,372-unit RSU grant, leaving her with direct beneficial ownership of 128,145 shares.